YH14659 + clopidogrel & aspirin
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Coronary Syndrome
Conditions
Acute Coronary Syndrome
Trial Timeline
Mar 1, 2012 → Apr 1, 2012
NCT ID
NCT01657071About YH14659 + clopidogrel & aspirin
YH14659 + clopidogrel & aspirin is a phase 1 stage product being developed by Yuhan for Acute Coronary Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT01657071. Target conditions include Acute Coronary Syndrome.
What happened to similar drugs?
20 of 20 similar drugs in Acute Coronary Syndrome were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01657071 | Phase 1 | Completed |
| NCT01422109 | Phase 1 | Completed |
Competing Products
20 competing products in Acute Coronary Syndrome